Hepatic lipase: a marker for cardiovascular disease risk and response to therapy
about
Transcriptional regulation of the human hepatic lipase (LIPC) gene promoterMetabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic miceInteraction between cholesteryl ester transfer protein and hepatic lipase encoding genes and the risk of type 2 diabetes: results from the Telde study.Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease.The expression of type III hyperlipoproteinemia: involvement of lipolysis genesLIGHT/TNFSR14 can regulate hepatic lipase expression by hepatocytes independent of T cells and Kupffer cells.Trans-ethnic fine-mapping of lipid loci identifies population-specific signals and allelic heterogeneity that increases the trait variance explained.Diplotyper: diplotype-based association analysisHepatic lipase, high density lipoproteins, and hypertriglyceridemia.Positive association of the hepatic lipase gene polymorphism c.514C > T with estrogen replacement therapy responseHepatic lipase gene -514C>T variant is associated with exercise training-induced changes in VLDL and HDL by lipoprotein lipaseDietary Fat Intake Modifies the Effect of a Common Variant in the LIPC Gene on Changes in Serum Lipid Concentrations during a Long-Term Weight-Loss Intervention Trial.Postprandial lipoprotein metabolism: VLDL vs chylomicrons.Genetic polymorphisms in fatty acid metabolism genes and colorectal cancer.The effect of hepatic lipase on coronary artery disease in humans is influenced by the underlying lipoprotein phenotypeLipid-regulating effect of traditional chinese medicine: mechanisms of actions.Regulation of hepatic lipase activity by sphingomyelin in plasma lipoproteins.Gender specific effect of LIPC C-514T polymorphism on obesity and relationship with plasma lipid levels in Chinese children.Genetic variability within the cholesterol lowering pathway and the effectiveness of statins in reducing the risk of MIAssociation studies of several cholesterol-related genes (ABCA1, CETP and LIPC) with serum lipids and risk of Alzheimer's disease.Common genetic variation in six lipid-related and statin-related genes, statin use and risk of incident nonfatal myocardial infarction and stroke.Improved cholesterol phenotype analysis by a model relating lipoprotein life cycle processes to particle size.Rapid and pervasive changes in genome-wide enhancer usage during mammalian development.Enhancing reverse cholesterol transport/raising HDL cholesterol: new options for prevention and treatment of cardiovascular disease.Endothelial lipase is synthesized by hepatic and aorta endothelial cells and its expression is altered in apoE-deficient mice.Interfacial properties of amphipathic beta strand consensus peptides of apolipoprotein B at oil/water interfaces.The ligand-binding function of hepatic lipase modulates the development of atherosclerosis in transgenic mice.Association between the Hepatic Lipase Promoter Region Polymorphism (-514 C/T) and the Presence and Severity of Premature Coronary Artery Disease.Hepatic lipase polymorphism and increased risk of peripheral arterial disease.Hepatic lipase activity is increased in non-alcoholic fatty liver disease beyond insulin resistance.A high carbohydrate diet induces the beneficial effect of the CC genotype of hepatic lipase C-514T polymorphism on the apoB100/apoAI ratio only in young Chinese males.Hepatic lipase gene polymorphism, pre-pregnancy overweight status and risk of preeclampsia among Peruvian women.
P2860
Q28306414-B6450D9C-7ACC-4038-A132-657394015855Q33782682-992602C9-092C-4667-912D-A185C346A795Q34071859-B8315614-2EC9-4D7F-9ECF-2C3177157D06Q34287868-B9B209E3-0FEE-4B10-A642-A5E2E4D689EEQ34326186-6EDFB8FA-1F68-47EA-8A6B-F2D95EC2D9D3Q34565128-96255E60-CD7B-4C71-A7F7-3AE9AF4D22FFQ34649888-32C07756-3AA8-463C-A3D6-BE1B78BE14B4Q34789910-599C954B-9024-41ED-B2A0-DA569C4F158BQ34805379-034C10A9-0602-4278-B8E4-D911ED0232EFQ35576667-7F2E300D-2C2B-4810-9205-3D67EE676E70Q35601711-9411A0B7-95AD-4B95-AAFA-BB06949ED25AQ35640027-35737460-B616-4668-A409-1E520FC742D3Q35692385-F2CE70EA-7A6D-4063-B887-93F5667C5885Q35714424-75DC8005-BFDE-47FD-8496-B2775C3D5843Q35784769-1476E026-9E94-4B20-ABBB-322B245825F3Q35961350-5DCC7EAF-74CC-4CB6-AA88-2880E764809CQ36032787-A5CFC365-B778-4825-9B0F-46599A31EE1FQ36057523-6BA5F2EC-B18A-4D59-A3EB-83CF4A74D318Q36301394-442B342D-E6E0-489E-B9E8-2D3786E98E2BQ36493774-8D5D2768-A548-4AE6-8504-2806E0E89F1BQ37330613-5721B2C7-E470-4098-964F-EBD4F575B8B7Q37430584-284F93B6-1DCC-44F1-BCBA-2F48D7E8CF3BQ37706673-09DFFDFE-4051-4C77-9C8A-216B51DC208FQ42339302-2007C77B-EA00-48B7-876F-DFBDCAF02FABQ44919525-EF145F5D-A3AD-4850-A584-9EE1768A7840Q44962073-0873CCAF-63F1-493F-8A7F-5CDD479D351EQ45013848-37D125E6-AACF-4572-9BEC-447147E49EAEQ45105632-593CD00B-FD1F-4E77-8C3B-E6896BC0EC7AQ46704788-BD7A144F-4E50-452B-9EAE-8F68F30E9E7EQ47844166-696F8C24-65CF-4CC8-80BC-5A934609CB67Q50915646-B71EDE1C-0C1E-4ABE-AE01-681D0091F7D4Q54629296-D22EF9E6-7BE2-434A-BC2F-AAEC958454E4
P2860
Hepatic lipase: a marker for cardiovascular disease risk and response to therapy
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Hepatic lipase: a marker for cardiovascular disease risk and response to therapy
@ast
Hepatic lipase: a marker for cardiovascular disease risk and response to therapy
@en
Hepatic lipase: a marker for cardiovascular disease risk and response to therapy
@nl
type
label
Hepatic lipase: a marker for cardiovascular disease risk and response to therapy
@ast
Hepatic lipase: a marker for cardiovascular disease risk and response to therapy
@en
Hepatic lipase: a marker for cardiovascular disease risk and response to therapy
@nl
prefLabel
Hepatic lipase: a marker for cardiovascular disease risk and response to therapy
@ast
Hepatic lipase: a marker for cardiovascular disease risk and response to therapy
@en
Hepatic lipase: a marker for cardiovascular disease risk and response to therapy
@nl
P2093
P1476
Hepatic lipase: a marker for cardiovascular disease risk and response to therapy
@en
P2093
Alberto Zambon
Gaetano Crepaldi
John D Brunzell
Paolo Pauletto
Samir S Deeb
P304
P356
10.1097/00041433-200304000-00010
P407
P577
2003-04-01T00:00:00Z